Home
>
National Drug Code (NDC)
>
SYNRIBO
SYNRIBO - 63459-177-14 - (omacetaxine mepesuccinate)
Drug Information of SYNRIBO
| Product NDC: | 63459-177 |
| Proprietary Name: | SYNRIBO |
| Non Proprietary Name: | omacetaxine mepesuccinate |
| Active Ingredient(s): | 3.5 mg/mL & nbsp; omacetaxine mepesuccinate |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of SYNRIBO
| Product NDC: | 63459-177 |
| Labeler Name: | Cephalon, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA203585 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20121026 |
Package Information of SYNRIBO
| Package NDC: | 63459-177-14 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (63459-177-14) > 1 mL in 1 VIAL, SINGLE-USE |
NDC Information of SYNRIBO
| NDC Code | 63459-177-14 |
| Proprietary Name | SYNRIBO |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (63459-177-14) > 1 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 63459-177 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | omacetaxine mepesuccinate |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20121026 |
| Marketing Category Name | NDA |
| Labeler Name | Cephalon, Inc. |
| Substance Name | OMACETAXINE MEPESUCCINATE |
| Strength Number | 3.5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
